Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Vascular Pharmaceuticals Logo
Vascular Pharmaceuticals Growth Score
30
CB Rank
264514
Heat Score
8
Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy.
Founded
obfuscation
PrivateSeries B Tarboro, North Carolina, United States1-10 www.vascularpharma.com
Biotechnology
Diabetes
Health Care
Overview

Vascular Pharmaceuticals
Total Funding
obfuscation
Growth Score
30
Heat Score
8

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score30
-2 pts
in past quarter
Heat Score 8
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Vascular Pharmaceuticals

CB Rank
264514
Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy.
Founded
obfuscation
PrivateSeries B Tarboro, North Carolina, United States1-10 www.vascularpharma.com
Biotechnology
Diabetes
Health Care

Funding Rounds

Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Debt Financing
OBF
in
obfuscation

Key People

  • Photo of David R. Clemmons
    David R. Clemmons: Co-Founder and Chief Scientific Officer
    Past Role: UNC Kenan-Flagler Business School, Chief of the Division of Endocrinology and Metabolism
  • Elizabeth Stoner Logo
    Elizabeth Stoner: Chief Development Officer

Details

Legal Name Vascular Pharmaceuticals, Inc.
Operating Status Active
Company Type For Profit
Founders  David R. Clemmons, Laura Maile
About the Company
Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy. The company specializes in the fields of biotechnology, medicine, and healthcare. It was founded in 2005 and headquartered in Tarboro, North Carolina.
Phone Number 919-345-7933
Contact Email office@vascularpharma.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

VPI-2690B
A monoclonal antibody drug candidate in Phase 2 trials aimed at treating diabetic nephropathy by targeting pathways activated by hyperglycemia to slow or reverse kidney damage.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B
obfuscation
Series B - Vascular Pharmaceuticals Logo
Series B - Vascular Pharmaceuticals
—
obfuscation
— Series B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4 Contacts 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$21.3KThis year, Vascular Pharmaceuticals is projected to spend $21.3K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Automated Hedging Logo
Automated Hedging
74
Deal Review Logo
Deal Review
73
Retirement / Pre-Retirement Planning Logo
Retirement / Pre-Retirement Planning
72

Actively Used Products

11Vascular Pharmaceuticals uses 11 technology products and services including HTML5, Microsoft Outlook, and  F5 NGINX, according to G2 Stack.

Active Website Tech Count

5Vascular Pharmaceuticals is actively using 5 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  ASP.NET 4.0.
Sub-Organizations
Frequently Asked Questions

Where is Vascular Pharmaceuticals's headquarters? Vascular Pharmaceuticals is located in Tarboro, North Carolina, United States.Who invested in Vascular Pharmaceuticals? Vascular Pharmaceuticals has 6 investors including Lumira Ventures and  MPM Capital.When was the last funding round for Vascular Pharmaceuticals? Vascular Pharmaceuticals closed its last funding round on
obfuscation
from a Series B round.Who are Vascular Pharmaceuticals's competitors? Alternatives and possible competitors to Vascular Pharmaceuticals may include Eli Lilly, AbbVie, and  Roche.How much funding has Vascular Pharmaceuticals raised to date? Vascular Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|